LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $73,300 | +144.3% | 38,377 | +134.5% | 0.00% | – |
| Q2 2022 | $30,000 | -97.3% | 16,363 | -84.2% | 0.00% | -100.0% |
| Q3 2018 | $1,107,000 | -89.5% | 103,741 | -85.8% | 0.01% | -89.8% |
| Q1 2017 | $10,497,000 | +5.6% | 731,985 | +1.9% | 0.05% | -7.5% |
| Q4 2016 | $9,937,000 | -0.4% | 718,505 | +30.2% | 0.05% | -8.6% |
| Q3 2016 | $9,973,000 | +283.7% | 551,900 | +204.7% | 0.06% | +241.2% |
| Q2 2016 | $2,599,000 | +64.7% | 181,114 | +37.2% | 0.02% | +88.9% |
| Q1 2016 | $1,578,000 | -75.6% | 132,044 | -78.0% | 0.01% | -81.2% |
| Q3 2015 | $6,454,000 | – | 600,951 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |